After the presence of the c-kit selective therapy administration (specified inhabition of CD117), the same as GIST, the EGIST are well responsed to this therapy, even when the tumors are at late stages such as invasion or metastasis.. Up to now immunohistochemistry has been indispensable for the diagnosis of EGIST in addition to the standard histopathology.